DUBLIN, Nov. 23, 2020 /PRNewswire/ -- The "Neural Implants Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Neural Implants Market Report
The neural implants market by revenue is expected to grow at a CAGR of 11% during the period 2020-2025.
The global brain implants market is one of the fastest-growing segments in the global neurological treatment devices industry. The growing prevalence of neurological diseases worldwide, coupled with rising awareness among patients about new treatment modalities for neurological disorders and the increasing availability of effective devices, is a major factor contributing to the industry growth.
Neural implant technology is highly innovative and is expected to influence the existing treatment modalities of neuropathic disorders and chronic neuropathic pain. The introduction of neural implants has been a significant breakthrough in neurological treatment modalities with their high potential in minimizing the occurrence of adverse events associated with Parkinson's Disease, chronic pain, epilepsy, and other neural disorders. Therefore, the adoption of neural implants is likely to increase at a phenomenal rate in the coming years.
Global Neural Implants Market Segmentation
This research report includes a detailed segmentation by product, end-users, application, geography. In 2019, the spinal cord stimulation (SCS) segment accounted for more than 62% of the global neural implants market share. The growth of the segment has been fueled primarily due to the increasing prevalence of neuropathic pain, particularly the upsurge of patients with failed back surgery syndrome (FBSS)/failed back syndrome (FBS), and the attempts to use strategies other than chronic opioid therapy for the treatment of chronic neuropathic pain. Implantable SCS systems are used to treat certain types of chronic pain, such as neuropathic pain. As an intervention for chronic pain, SCS has proven an effective alternative.
The chronic pain segment will cross USD 4 billion by 2025. According to the WHO, an estimated 22% of the world's primary care patients have chronic debilitating pain making chronic pain a global challenge to be addressed by healthcare professionals. The incidence/prevalence of chronic pain is increasing rapidly worldwide. It affects 28-65% of the population in the US. Developing countries face a large burden of chronic pain than developed regions. Thus, the rising burden of chronic pain is likely to fuel the growth of the segment.
In 2019, hospitals' end-user segment constituted over 56% of the global neural implants market share. Healthcare professionals in hospitals are using neural implants for treating symptoms associated with neuropathic pain and neurodegenerative disorders. The industry is growing at a healthy rate and is likely to grow during the forecast period. The high adoption of the latest generation implants and the increased preference among patients with an increased risk of neurological diseases for visiting hospitals for diagnosis and treatment contribute to the segment's growth.
Insights by Vendors
The global neural implants market share is highly consolidated, with major vendors accounting for dominant shares. Key vendors are offering a broad range of conventional as well as latest-generation neural implants for end-users. Medtronic, Abbott, Boston Scientific, NEVRO, and LivaNova are the key players in the industry.
These vendors compete based on technology advances, accuracy features, regulatory approvals, marketing strategies, and distribution channels. These companies have a wide geographic footprint, diversified product portfolio, and a strong focus on product innovation, strategic mergers & acquisitions, and R&D activities.
- Boston Scientific
Other Prominent Vendors
- Aleva Neurotherapeutics
- Beijing PINS Medical
- Nalu Medical
- Saluda Medical
- GTX Medical
- SetPoint Medical
Key Topics Covered:
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of the Study
4.4 Market Segments
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7.1 Neural Implants: An Overview
8 Market Opportunities & Trends
8.1 Emergence of Latest Generation Neural Implants
8.2 Promising Investigational Devices
8.3 New Product Approvals/Launches
9 Market Growth Enablers
9.1 Rising Target Patient Pool Globally
9.2 Growing Popularity of MR-Conditional Neural Implants
9.3 Increasing Uptake of Minimally Invasive Pain Relief Treatment
9.4 Use of High-Frequenecy Neuromodulation Therapy
10 Market Restraints
10.1 Risks & Complications Associated With Neural Implants
10.2 Stringent Regulations Associated With Neural Implants
10.3 Limited Availability of Skilled Neurologists/Neurosurgeons
10.4 High Cost of Neural Implants
11 Market Landscape
11.1 Market Overview
11.2 COVID-19 Impact on the Global Neural Implants Market
11.3 Market Size & Forecast
11.4 Five Forces Analysis
12 Neural Implants Market by Product
12.1 Snapshot & Growth Engine
13 Neural Implants Market by Application
13.1 Snapshot & Growth Engine
13.3 Chronic Pain
13.4 Parkinson's Disease
14 Neural Implants Market by End-User
14.1 Snapshot & Growth Engine
14.4 Specialized Neurological Centers
14.5 Outpatient Surgery Centers
15 Neural Implants Market by Geography
15.1 Snapshot & Growth Engine
15.2 Geographic Overview
For more information about this report visit https://www.researchandmarkets.com/r/t7vo9t
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets